<i>Acinetobacter baumannii</i>: evolution of a global pathogen

Pathogens and Disease - Tập 71 Số 3 - Trang 292-301 - 2014
Luísa C. S. Antunes1, Paolo Visca1, K. J. Towner2
1Department of Sciences, Roma Tre University, Rome, Italy
2Department of Clinical Microbiology, Nottingham University Hospitals NHS Trust, Queen's Medical Centre, Nottingham, UK

Tóm tắt

Từ khóa


Tài liệu tham khảo

Adams, 2008, Comparative genome sequence analysis of multidrug-resistant Acinetobacter baumannii, J Bacteriol, 190, 8053, 10.1128/JB.00834-08

Al-Sweih, 2011, Emergence of tigecycline and colistin resistance in Acinetobacter species isolated from patients in Kuwait hospitals, J Chemother, 23, 13, 10.1179/joc.2011.23.1.13

Antunes, 2011a, Deciphering the multifactorial nature of Acinetobacter baumannii pathogenicity, PLoS ONE, 6, e22674, 10.1371/journal.pone.0022674

Antunes, 2011b, Genome-assisted identification of putative iron-utilization genes in Acinetobacter baumannii and their distribution among a genotypically diverse collection of clinical isolates, Res Microbiol, 162, 279, 10.1016/j.resmic.2010.10.010

Bentancor, 2012a, Identification of Ata, a multifunctional trimeric autotransporter of Acinetobacter baumannii, J Bacteriol, 194, 3950, 10.1128/JB.06769-11

Bentancor, 2012b, Poly-N-acetyl-β-(1-6)- glucosamine is a target for protective immunity against Acinetobacter baumannii infections, Infect Immun, 80, 651, 10.1128/IAI.05653-11

Bergogne-Bérézin, 1996, Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features, Clin Microbiol Rev, 9, 148, 10.1128/CMR.9.2.148

Bouvet, 1986, Taxonomy of the genus Acinetobacter with the recognition of Acinetobacter baumannii sp. nov., Acinetobacter haemolyticus sp. nov., Acinetobacter johnsonii sp. nov., and Acinetobacter junii sp. nov. and emended descriptions of Acinetobacter calcoaceticus and Acinetobacter lwoffii, Int J Syst Bacteriol, 36, 228, 10.1099/00207713-36-2-228

Breslow, 2011, Morphine, but not trauma, sensitizes to systemic Acinetobacter baumannii infection, J Neuroimmune Pharmacol, 6, 551, 10.1007/s11481-011-9303-6

Cai, 2012, Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies, J Antimicrob Chemother, 67, 1607, 10.1093/jac/dks084

Camarena, 2010, Molecular mechanisms of ethanol-induced pathogenesis revealed by RNA-sequencing, PLoS Pathog, 6, e1000834, 10.1371/journal.ppat.1000834

Centers for Disease Control and Prevention, 2004, Acinetobacter baumannii infections among patients at military medical facilities treating injured US service members, 2002-2004, MMWR, 53, 1063

Chan, 2012, Defining bacterial species in the genomic era: insights from the genus Acinetobacter, BMC Microbiol, 12, 302, 10.1186/1471-2180-12-302

Chang, 2000, Community-acquired Acinetobacter meningitis in adults, Infection, 28, 395, 10.1007/s150100070013

Choi, 2005, Outer membrane protein 38 of Acinetobacter baumannii localizes to the mitochondria and induces apoptosis of epithelial cells, Cell Microbiol, 7, 1127, 10.1111/j.1462-5822.2005.00538.x

Breij, 2010, Do biofilm formation and interactions with human cells explain the clinical success of Acinetobacter baumannii?, PLoS ONE, 5, e10732, 10.1371/journal.pone.0010732

Breij, 2012, Differences in Acinetobacter baumannii strains and host innate immune response determine morbidity and mortality in experimental pneumonia, PLoS ONE, 7, e30673, 10.1371/journal.pone.0030673

Nocera, 2011, Genome organization of epidemic Acinetobacter baumannii strains, BMC Microbiol, 11, 224, 10.1186/1471-2180-11-224

Diancourt, 2010, The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool, PLoS ONE, 5, e10034, 10.1371/journal.pone.0010034

Dijkshoorn, 2007, An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii, Nat Rev Microbiol, 5, 939, 10.1038/nrmicro1789

Eijkelkamp, 2011, Adherence and motility characteristics of clinical Acinetobacter baumannii isolates, FEMS Microbiol Lett, 323, 44, 10.1111/j.1574-6968.2011.02362.x

Eijkelkamp, 2013, H-NS plays a role in expression of Acinetobacter baumannii virulence features, Infect Immun, 81, 2574, 10.1128/IAI.00065-13

Evans, 2013, The rise of carbapenem-resistant Acinetobacter baumannii, Curr Pharm Des, 19, 223, 10.2174/138161213804070285

Eveillard, 2010, The virulence variability of different Acinetobacter baumannii strains in experimental pneumonia, J Infect, 60, 154, 10.1016/j.jinf.2009.09.004

Eveillard, 2013, Reservoirs of Acinetobacter baumannii outside the hospital and potential involvement in emerging human community-acquired infections, Int J Infect Dis, 17, e802, 10.1016/j.ijid.2013.03.021

Falagas, 2007, Attributable mortality of Acinetobacter baumannii: no longer a controversial issue, Crit Care, 11, 134, 10.1186/cc5911

Falagas, 2009, Nephrotoxicity of colistin: new insight into an old antibiotic, Clin Infect Dis, 48, 1729, 10.1086/599226

Falagas, 2007, Community-acquired Acinetobacter infections, Eur J Clin Microbiol Infect Dis, 26, 857, 10.1007/s10096-007-0365-6

Fang, 2008, New insights into transcriptional regulation by H-NS, Curr Opin Microbiol, 11, 113, 10.1016/j.mib.2008.02.011

Farrugia, 2013, The complete genome and phenome of a community-acquired Acinetobacter baumannii, PLoS ONE, 8, e58628, 10.1371/journal.pone.0058628

Fattahian, 2011, Protection against Acinetobacter baumannii infection via its functional deprivation of biofilm associated protein (Bap), Microb Pathog, 51, 402, 10.1016/j.micpath.2011.09.004

Fondi, 2010, Exploring the evolutionary dynamics of plasmids: the Acinetobacter pan-plasmidome, BMC Evol Biol, 10, 59, 10.1186/1471-2148-10-59

Fondi, 2013, The genome sequence of the hydrocarbon-degrading Acinetobacter venetianus VE-C3, Res Microbiol, 164, 439, 10.1016/j.resmic.2013.03.003

Gaddy, 2012, Role of acinetobactin- mediated iron acquisition functions in the interaction of Acinetobacter baumannii strain ATCC 19606T with human lung epithelial cells, Galleria mellonella caterpillars, and mice, Infect Immun, 80, 1015, 10.1128/IAI.06279-11

Giannouli, 2013, Virulence-related traits of epidemic Acinetobacter baumannii strains belonging to the international clonal lineages I-III and to the emerging genotypes ST25 and ST78, BMC Infect Dis, 13, 282, 10.1186/1471-2334-13-282

Girlich, 2010, First isolation of the blaOXA-23 carbapenemase gene from an environmental Acinetobacter baumannii isolate, Antimicrob Agents Chemother, 54, 578, 10.1128/AAC.00861-09

Iacono, 2008, Whole-genome pyrosequencing of an epidemic multidrug-resistant Acinetobacter baumannii strain belonging to the European clone II group, Antimicrob Agents Chemother, 52, 2616, 10.1128/AAC.01643-07

Imperi, 2011, The genomics of Acinetobacter baumannii: insights into genome plasticity, antimicrobial resistance and pathogenicity, IUBMB Life, 63, 1068, 10.1002/iub.531

Iwashkiw, 2012, Identification of a general O-linked protein glycosylation system in Acinetobacter baumannii and its role in virulence and biofilm formation, PLoS Pathog, 8, e1002758, 10.1371/journal.ppat.1002758

Jacobs, 2010, Inactivation of phospholipase D diminishes Acinetobacter baumannii pathogenesis, Infect Immun, 78, 1952, 10.1128/IAI.00889-09

Jacobs, 2012, Characterization of the Acinetobacter baumannii growth phase-dependent and serum responsive transcriptomes, FEMS Immunol Med Microbiol, 64, 403, 10.1111/j.1574-695X.2011.00926.x

Jensen, 2003, The hidden lifestyles of Bacillus cereus and relatives, Environ Microbiol, 5, 631, 10.1046/j.1462-2920.2003.00461.x

Joly-Guillou, 2005, Clinical impact and pathogenicity of Acinetobacter, Clin Microbiol Infect, 11, 868, 10.1111/j.1469-0691.2005.01227.x

Karah, 2012, Insights into the global molecular epidemiology of carbapenem non-susceptible clones of Acinetobacter baumannii, Drug Resist Updat, 15, 237, 10.1016/j.drup.2012.06.001

Keen, 2010, Changes in the incidences of multidrug-resistant and extensively drug-resistant organisms isolated in a military medical center, Infect Control Hosp Epidemiol, 31, 728, 10.1086/653617

Kempf, 2012, Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options, Int J Antimicrob Agents, 39, 105, 10.1016/j.ijantimicag.2011.10.004

Kenyon, 2013, Variation in the complex carbohydrate biosynthesis loci of Acinetobacter baumannii genomes, PLoS ONE, 16, e62160, 10.1371/journal.pone.0062160

Scola, 2004, Acinetobacter baumannii in human body louse, Emerg Infect Dis, 10, 1671, 10.3201/eid1009.040242

Lawrence, 2005, Common themes in the genome strategies of pathogens, Curr Opin Genet Dev, 15, 584, 10.1016/j.gde.2005.09.007

Lee, 2006, Adherence of Acinetobacter baumannii strains to human bronchial epithelial cells, Res Microbiol, 157, 360, 10.1016/j.resmic.2005.09.011

Lees-Miller, 2013, A common pathway for O-linked protein glycosylation and synthesis of capsule in Acinetobacter baumannii, Mol Microbiol, 89, 816, 10.1111/mmi.12300

Li, 2012, Bioinformatic analysis of the Acinetobacter baumannii phage AB1 genome, Gene, 507, 125, 10.1016/j.gene.2012.07.029

Lin, 2012, Inhibition of LpxC protects mice from resistant Acinetobacter baumannii by modulating inflammation and enhancing phagocytosis, MBio, 3, e00312, 10.1128/mBio.00312-12

Malhotra, 2012, Genome Sequence of Acinetobacter sp. Strain HA, Isolated from the Gut of the Polyphagous Insect Pest Helicoverpa armigera, J Bacteriol, 194, 5156, 10.1128/JB.01194-12

McConnell, 2013, Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models, FEMS Microbiol Rev, 37, 130, 10.1111/j.1574-6976.2012.00344.x

Mera, 2010, Acinetobacter baumannii 2002-2008: increase of carbapenem-associated multiclass resistance in the United States, Microb Drug Resist, 16, 209, 10.1089/mdr.2010.0052

Mortensen, 2012, Host-microbe interactions that shape the pathogenesis of Acinetobacter baumannii infection, Cell Microbiol, 14, 1336, 10.1111/j.1462-5822.2012.01817.x

Niu, 2008, Isolation and characterization of an autoinducer synthase from Acinetobacter baumannii, J Bacteriol, 190, 3386, 10.1128/JB.01929-07

Pallen, 2007, Bacterial pathogenomics, Nature, 449, 835, 10.1038/nature06248

Pantophlet, 2008, Acinetobacter Molecular Biology, 61

Peleg, 2008, Acinetobacter baumannii: emergence of a successful pathogen, Clin Microbiol Rev, 21, 538, 10.1128/CMR.00058-07

Peleg, 2012, The success of Acinetobacter species; genetic, metabolic and virulence attributes, PLoS ONE, 7, e46984, 10.1371/journal.pone.0046984

Poirel, 2011, Genetic basis of antibiotic resistance in pathogenic Acinetobacter species, IUBMB Life, 63, 1061, 10.1002/iub.532

Poirel, 2012, Carbapenemase-producing Acinetobacter spp. in Cattle, France, Emerg Infect Dis, 18, 523, 10.3201/eid1803.111330

Roca, 2012, The Acinetobacter baumannii oxymoron: commensal hospital dweller turned pan-drug-resistant menace, Front Microbiol, 3, 148, 10.3389/fmicb.2012.00148

Russo, 2009, Penicillin-binding protein 7/8 contributes to the survival of Acinetobacter baumannii in vitro and in vivo, J Infect Dis, 199, 513, 10.1086/596317

Russo, 2010, The K1 capsular polysaccharide of Acinetobacter baumannii strain 307-0294 is a major virulence factor, Infect Immun, 78, 3993, 10.1128/IAI.00366-10

Sahl, 2011, Genomic comparison of multi-drug resistant invasive and colonizing Acinetobacter baumannii isolated from diverse human body sites reveals genomic plasticity, BMC Genomics, 12, 291, 10.1186/1471-2164-12-291

Sahl, 2013, Evolution of a pathogen: a comparative genomics analysis identifies a genetic pathway to pathogenesis in Acinetobacter, PLoS ONE, 8, e54287, 10.1371/journal.pone.0054287

Seiffert, 2013, Extended-spectrum cephalosporin-resistant Gram-negative organisms in livestock: an emerging problem for human health, Drug Resist Updat, 16, 22, 10.1016/j.drup.2012.12.001

Smith, 2007, New insights into Acinetobacter baumannii pathogenesis revealed by high-density pyrosequencing and transposon mutagenesis, Genes Dev, 21, 601, 10.1101/gad.1510307

Talbot, 2006, Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America, Clin Infect Dis, 42, 657, 10.1086/499819

Tayabali, 2012, Comparison of the virulence potential of Acinetobacter strains from clinical and environmental sources, PLoS ONE, 7, e37024, 10.1371/journal.pone.0037024

Tomaras, 2003, Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: involvement of a novel chaperone-usher pili assembly system, Microbiology, 149, 3473, 10.1099/mic.0.26541-0

Tomaras, 2008, Characterization of a two-component regulatory system from Acinetobacter baumannii that controls biofilm formation and cellular morphology, Microbiology, 154, 3398, 10.1099/mic.0.2008/019471-0

Towner, 2009, Acinetobacter: an old friend, but a new enemy, J Hosp Infect, 73, 355, 10.1016/j.jhin.2009.03.032

Vallenet, 2008, Comparative analysis of Acinetobacters: three genomes for three lifestyles, PLoS ONE, 3, e1805, 10.1371/journal.pone.0001805

Wisplinghoff, 1999, Risk factors for nosocomial bloodstream infections due to Acinetobacter baumannii: a case-control study of adult burn patients, Clin Infect Dis, 28, 59, 10.1086/515067

Zhan, 2012, Comparative analysis of the complete genome of an Acinetobacter calcoaceticus strain adapted to a phenol-polluted environment, Res Microbiol, 163, 36, 10.1016/j.resmic.2011.10.006

Zordan, 2011, Multidrug-resistant Acinetobacter baumannii in veterinary clinics, Germany, Emerg Infect Dis, 17, 1751, 10.3201/eid1709.101931